| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1090754894 |
| P356 | DOI | 10.1038/S41598-017-05997-4 |
| P932 | PMC publication ID | 5522460 |
| P698 | PubMed publication ID | 28733623 |
| P50 | author | Przemyslaw Grudnik | Q56863430 |
| Julia Witkowska | Q59681993 | ||
| Artur Gieldon | Q63388253 | ||
| Elzbieta Jankowska | Q64006727 | ||
| Przemyslaw Karpowicz | Q84315116 | ||
| Grzegorz Dubin | Q40717413 | ||
| P2093 | author name string | Małgorzata Giżyńska | |
| Przemysław Golik | |||
| P2860 | cites work | XDSAPP: a graphical user interface for the convenient processing of diffraction data usingXDS | Q57973386 |
| Purification and characterization of proteasomes from Saccharomyces cerevisiae | Q81132246 | ||
| Purification of proteasomes, proteasome subcomplexes, and proteasome-associated proteins from budding yeast | Q81786895 | ||
| Analysing properties of proteasome inhibitors using kinetic and X-ray crystallographic studies | Q83477555 | ||
| Mechanism of gate opening in the 20S proteasome by the proteasomal ATPases | Q24564109 | ||
| MolProbity: all-atom structure validation for macromolecular crystallography | Q24649111 | ||
| PHENIX: a comprehensive Python-based system for macromolecular structure solution | Q24654617 | ||
| Docking of the proteasomal ATPases' carboxyl termini in the 20S proteasome's alpha ring opens the gate for substrate entry | Q24674433 | ||
| A gated channel into the proteasome core particle | Q27627907 | ||
| Structural basis for the activation of 20S proteasomes by 11S regulators | Q27628418 | ||
| The structure of the mammalian 20S proteasome at 2.75 A resolution | Q27638997 | ||
| Interactions of PAN's C-termini with archaeal 20S proteasome and implications for the eukaryotic proteasome–ATPase interactions | Q27646619 | ||
| Structural Models for Interactions between the 20S Proteasome and Its PAN/19S Activators | Q27658058 | ||
| Structure of a Blm10 Complex Reveals Common Mechanisms for Proteasome Binding and Gate Opening | Q27660222 | ||
| An atomic structure of the human 26S proteasome | Q27720380 | ||
| Structure of 20S proteasome from yeast at 2.4 A resolution | Q27735081 | ||
| XDS | Q27860472 | ||
| Molecular replacement with MOLREP | Q27860539 | ||
| The Amber biomolecular simulation programs | Q27860745 | ||
| Overview of the CCP4 suite and current developments | Q27860782 | ||
| The ubiquitin system | Q27860803 | ||
| Free R value: a novel statistical quantity for assessing the accuracy of crystal structures | Q27860894 | ||
| REFMAC5 for the refinement of macromolecular crystal structures | Q27860905 | ||
| Features and development of Coot | Q27861079 | ||
| Differential roles of the COOH termini of AAA subunits of PA700 (19 S regulator) in asymmetric assembly and activation of the 26 S proteasome | Q28294192 | ||
| Role of the ubiquitin proteasome system in Parkinson's disease | Q33307874 | ||
| The 1.9 A structure of a proteasome-11S activator complex and implications for proteasome-PAN/PA700 interactions. | Q33987362 | ||
| Proteasome activation is a mechanism for pyrazolone small molecules displaying therapeutic potential in amyotrophic lateral sclerosis | Q34249469 | ||
| The axial channel of the 20S proteasome opens upon binding of the PA200 activator | Q34555139 | ||
| Interplay between Structure and Charge as a Key to Allosteric Modulation of Human 20S Proteasome by the Basic Fragment of HIV-1 Tat Protein | Q35843506 | ||
| The pore of activated 20S proteasomes has an ordered 7-fold symmetric conformation | Q36065854 | ||
| Drug discovery in the ubiquitin-proteasome system. | Q36525810 | ||
| Structure of the human 26S proteasome at a resolution of 3.9 Å. | Q37102327 | ||
| The persisting challenge of selective and specific proteasome inhibition | Q37358550 | ||
| Structural insights into the functional cycle of the ATPase module of the 26S proteasome | Q37640400 | ||
| Proteasomal dysfunction in aging and Huntington disease | Q37818887 | ||
| Proteasome inhibitors: an expanding army attacking a unique target | Q37979388 | ||
| Degradation of damaged proteins: the main function of the 20S proteasome | Q38021167 | ||
| The proteasome in health and disease. | Q38046939 | ||
| High-resolution cryo-EM structure of the proteasome in complex with ADP-AlFx | Q39010593 | ||
| Dissecting a role of a charge and conformation of Tat2 peptide in allosteric regulation of 20S proteasome. | Q39194017 | ||
| RASMOL AB - new functionalities in the program for structure analysis. | Q40596865 | ||
| Purification of large cytosolic proteases for in vitro assays: 20S and 26S proteasomes | Q44249587 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6177 | |
| P577 | publication date | 2017-07-21 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Crystal structure of a low molecular weight activator Blm-pep with yeast 20S proteasome - insights into the enzyme activation mechanism | |
| P478 | volume | 7 |
| Q64096816 | A Practical Review of Proteasome Pharmacology |
| Q91659959 | Aim for the core: suitability of the ubiquitin-independent 20S proteasome as a drug target in neurodegeneration |
| Q90700693 | All About the Core: A Therapeutic Strategy to Prevent Protein Accumulation with Proteasome Core Particle Stimulators |
| Q93273338 | Comparative Structural Analysis of 20S Proteasome Ortholog Protein Complexes by Native Mass Spectrometry |
| Q93210381 | Proline- and Arginine-Rich Peptides as Flexible Allosteric Modulators of Human Proteasome Activity |
| Q92923068 | Proteasomes and Several Aspects of Their Heterogeneity Relevant to Cancer |
| Q91663542 | Pyrazolones Activate the Proteasome by Gating Mechanisms and Protect Neuronal Cells from β-Amyloid Toxicity |
| Q95650650 | The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges |
Search more.